
### [NCIT:C6432](http://purl.obolibrary.org/obo/NCIT_C6432)
**Label:** Multiple Endocrine Neoplasia

**Subclasses:** [NCIT:C3225](http://purl.obolibrary.org/obo/NCIT_C3225) (Multiple Endocrine Neoplasia Type 1), [NCIT:C3227](http://purl.obolibrary.org/obo/NCIT_C3227) (Multiple Endocrine Neoplasia Type 2B), [NCIT:C3226](http://purl.obolibrary.org/obo/NCIT_C3226) (Multiple Endocrine Neoplasia Type 2A), [NCIT:C123329](http://purl.obolibrary.org/obo/NCIT_C123329) (Multiple Endocrine Neoplasia Type 2), 

**Class expressions from DL-Learner:**

- [NCIT:C36180](http://purl.obolibrary.org/obo/NCIT_C36180) (Multifocal Lesion) 56.25%
- [CL:0002258](http://purl.obolibrary.org/obo/CL_0002258) (thyroid follicular cell) 56.25%
- [CL:0002257](http://purl.obolibrary.org/obo/CL_0002257) (epithelial cell of thyroid gland) 56.25%
- Thing 52.26%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39812](http://purl.obolibrary.org/obo/NCIT_C39812) (Metanephric Adenofibroma))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39811](http://purl.obolibrary.org/obo/NCIT_C39811) (t(5;11)(q35;q13)))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39810](http://purl.obolibrary.org/obo/NCIT_C39810) (Type 2 Renal Papillary Adenoma))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39809](http://purl.obolibrary.org/obo/NCIT_C39809) (Type 1 Renal Papillary Adenoma))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39808](http://purl.obolibrary.org/obo/NCIT_C39808) (Asymptomatic Mass))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39807](http://purl.obolibrary.org/obo/NCIT_C39807) (Mucinous Tubular and Spindle Cell Carcinoma of the Kidney))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39806](http://purl.obolibrary.org/obo/NCIT_C39806) (NONO-TFE3 Fusion Protein Expression))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39805](http://purl.obolibrary.org/obo/NCIT_C39805) (PSF-TFE3 Fusion Protein Expression))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39803](http://purl.obolibrary.org/obo/NCIT_C39803) (PRCC-TFE3 Fusion Protein Expression))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39802](http://purl.obolibrary.org/obo/NCIT_C39802) (Renal Cell Carcinoma Associated with inv(X)(p11;q12)))) 41.61%


